Design and evaluation of interventions promoting periconceptional multivitamin use

American Journal of Preventive Medicine

Volumn 25, Issue 1, 2003, Pages 17-24

  Lawrence, Jean M ^a   Watkins, Margaret L ^b   Ershoff, Daniel ^c   Petitti, Diana B ^a   Chiu, Vicki ^a   Postlethwaite, Debbie ^a   Erickson, J David ^b  

^a KAISER PERMANENTE   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; MULTIVITAMIN;

ADULT; ARTICLE; CONCEPTION; CONTROLLED STUDY; EVALUATION; FEMALE; HEALTH EDUCATION; HEALTH SURVEY; HUMAN; NORMAL HUMAN; PRIMARY MEDICAL CARE; TREATMENT OUTCOME; UNITED STATES; VITAMIN SUPPLEMENTATION;

EID: 0037671289     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-3797(03)00097-7     Document Type: Article

References (28)

1. Botto L.D., Moore C.A., Khoury M.J., Erickson J.D. Neural-tube defects. N Engl J Med. 341:1999;1509-1519.
2. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Morb Mortal Wkly Rep. 41:1992;1-7.
3. Prevention of neural tube defects results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group . Lancet. 338:1991;131-137.
4. Laurence K.M., James N., Miller M.H., Tennant G.B., Campbell H. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. BMJ. 282:1981;1509-1511.
5. Czeizel A.E., Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 327:1992;1832-1835.
6. Kirke P.N., Daly L.E., Elwood J.H. A randomised trial of low dose folic acid to prevent neural tube defects. The Irish Vitamin Study Group. Arch Dis Child. 67:1992;1442-1446.
7. Scott J., Kirke P., Molloy A., Daly L., Weir D. The role of folate in the prevention of neural-tube defects. Proc Nutr Soc. 53:1994;631-636.
8. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep. 41:1992;1-7.
9. March of Dimes Birth Defects Foundation. Folic acid and the prevention of birth defects. A national survey of pre-pregnancy awareness and behavior among women of childbearing age 1995-2002. White Plains NY: March of Dimes Foundation, May 2002.
10. Food standards amendment of the standards of identity for enriched grain products to require addition of folic acid . Fed Reg. 61:1996;8781-8797.
11. Lawrence J.M., Petitti D.B., Watkins M., Umekubo M.A. Time trends in serum folate levels in clinical specimens following food fortification. Lancet. 354:1999;915-916.
12. Jacques P.F., Selhub J., Bostom A.G., Wilson P.W.F., Rosenberg I.H. The effect of folic acid fortification on plasma folate and total homocysteine contentrations. N Engl J Med. 340:1999;1449-1454.
13. Lawrence J.M., Chiu V., Petitti D.B. Fortification of foods with folic acid. N Engl J Med. 343:2000;970.
14. Erickson J.D., Mulinare J., Yang Q., et al. Folate status in women of childbearing age, by race/ethnicity - United States, 1999-2000. MMWR Morb Mortal Wkly Rep. 51:2002;808-810.
15. Henshaw S.K. Unintended pregnancy in the United States. Fam Plann Perspect. 30:1998;24-29 46.
16. Lefebvre R.C., Flora J.A. Social marketing and public health intervention. Health Educ Q. 15:1988;299-315.
17. Siegel M., Doner L. Marketing public health strategies to promote social change . 1998;Aspen Publishers, Gaithensburg MD.
18. Strecher V.J., Rosenstock I.M. The health belief model. Glanz K., Lewis F.M., Rimer B.K. Health behavior and health education theory, research, and practice . 2nd ed:1997;41-59 Jossey Bass Publishers, San Francisco.
19. Prochaska J.O., DiClemente C.C. Stages and processes of self-change of smoking toward an integrative model of change . J Consult Clin Psychol. 51:1983;390-395.
20. Prochaska J.O., Velicer W.F. The transtheoretical model of health behavior change. Am J Health Promot. 12:1977;38-48.
21. Cook T.D., Campbell D.T. Quasi-experimentation design & analysis issues for field settings. 1979;Houghton Mifflin, Boston.
22. Centers for Disease Control and Prevention. Behavioral risk factor surveillance system survey questionnaire. Atlanta, GA: Centers for Disease Control and Prevention, 1997.
23. Gillings D., Makuc D., Siegel E. Analysis of interrupted time series mortality trends an example to evaluate regionalized perinatal care . Am J Public Health. 71:1981;38-46.
24. Lyon Daniel K, Knudson T, Watkins M. Health care provider recommendations and barriers to change in folic acid prevention of neural tube defects. Paper presented at annual conference of American Public Health Association, Atlanta, GA, November 2001.
25. Last J.M. A dictionary of epidemiology. 3rd ed:1995;Oxford University Press, New York.
26. Honein M.A., Paulozzi L.J., Mathews T.J., Erickson J.D., Wong L.-Y.C. Impact of folic acid fortification of the U.S. food supply on the occurrence of neural tube defects. JAMA. 285:2001;1981-1986.
27. Persad V.L., Van den Hof M.C., Dube J.M., Zimmer P. Incidence of open neural tube defects in Novia Scotia after folic acid fortification. Can Med Assoc J. 167:2002;241-245.
28. Than L.C., Watkins M., Daniel K.L. Serum folate levels among women attending family planning clinics - Georgia, 2000. MMWR Morb Mortal Wkly Rep. 51:2002;3-7.